• OncoCyte (NYSEAMERICAN:OCX) Upgraded by Zacks Investment Research to Buy

    Zacks Investment Research upgraded shares of OncoCyte (NYSEAMERICAN:OCX) from a hold rating to a buy rating in a research note published on …

    Read More
  • 0 0